Brief: Cyclerion Announces Cy6463 Clinical Pipeline Progress And First Quarter 2022 Financial Results

Korsana Biosciences

04/05/2022 23:00

May 4 (Reuters) - Cyclerion Therapeutics Inc  CYCN.O :
    * CYCLERION ANNOUNCES CY6463 CLINICAL PIPELINE PROGRESS AND
FIRST
QUARTER 2022 FINANCIAL RESULTS
    * CYCLERION THERAPEUTICS INC - NET LOSS WAS APPROXIMATELY
$13.0
MILLION FOR Q1 OF 2022

Source text for Eikon:  ID:nGNX4Wn8P4 
Further company coverage:  CYCN.O 

 ((Reuters.Briefs@thomsonreuters.com;))